Hence, while current findings point towards an oncogenic role for RYK in several epithelial cancers, including prostate cancer, a deeper understanding of RYK functions during normal prostate tissue homeostasis and prostate tumorigenesis is needed to ascertain the mechanism(s) whereby this receptor tyrosine kinase could contribute to prostate cancer growth. This evidence concerns the gene NTRK1 and prostate carcinoma.